Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 2, 2025
Reporting Period: Fiscal Year 2025 (ending December 31, 2025)
Context: This filing serves as a Regulation FD disclosure to inform investors that senior management will reaffirm full-year financial guidance during investor meetings scheduled between June 2 and June 30, 2025. An Investor Conference is also scheduled for June 16, 2025.
Key Financial Metrics
The filing provides forward-looking guidance for Fiscal Year 2025 rather than historical financial results for a completed period.
- GAAP Diluted EPS Guidance: Approximately $14.68
- Adjusted EPS Guidance (Non-GAAP): Approximately $16.25
- Revenue, Profit, Cash Flow, Debt, Liquidity: The filing text does not provide specific values for total revenue, net profit, operating cash flow, debt levels, or liquidity metrics.
Material Changes and Guidance Reconciliation
The guidance reaffirmed in this report is consistent with the guidance issued in the Company's press release dated April 30, 2025. No material changes to the previously issued guidance are indicated.
Reconciliation of GAAP to Adjusted EPS (FY 2025 Projected):
| Item | Amount (Approx.) |
|---|---|
| GAAP Diluted EPS | $14.68 |
| Amortization of identifiable intangibles | $0.49 |
| Put/call valuation adjustments (non-consolidating minority interest) | $1.35 |
| Value creation initiatives | $0.20 |
| Cumulative net tax impact | ($0.47) |
| Adjusted EPS | $16.25 |
Note: Adjusted results exclude the future impact of items that cannot be estimated at this time.
Outlook, Risks, and Unusual Items
- Management Commentary: Management intends to present on strategic direction, operational progress, and future performance expectations at the June 16, 2025 Investor Conference.
- Non-GAAP Measures: The company utilizes Adjusted EPS to provide a perspective on core operating performance, excluding specific valuation adjustments and amortization. Management states this should be considered in addition to, not as a substitute for, GAAP EPS.
- Risks and Contingencies: The filing includes a standard cautionary statement regarding forward-looking statements. Actual results may differ due to risks, uncertainties, and assumptions detailed in the "Risk Factors" section of other SEC filings. No specific new risks or unusual items are detailed in this text.
Investor Verification Checklist
- Verify the full reconciliation of GAAP to Non-GAAP measures in the company's official press release dated April 30, 2025.
- Review the "Risk Factors" section of the most recent 10-K or 10-Q to understand the specific uncertainties affecting the FY 2025 guidance.
- Confirm the details of the June 16, 2025 Investor Conference via the company's Investor Relations page for live or replay access.
- Monitor future filings for updates on the "value creation initiatives" and "put/call valuation adjustments" included in the Adjusted EPS calculation.